Case Report: Vigil Therapy in Pathology Defined High-Risk Differentiated Thyroid Cancer Compounded by Post Ablation High-Risk Factors

Minal Barve¹,², Radhika Barve¹, Jennifer Rao¹, Luisa Manning³, Donald D Rao⁴, Ned Adams¹, Neil Senzer¹,³,⁴ and John Nemunaitis¹-⁵*

¹Physician Investigator, Mary Crowley Cancer Research Centers, USA
²Physician Investigator, Texas Oncology, USA
³Physician Investigator, Gradalis Inc, USA
?Scientific Director, Strike Bio, USA
?Physician Investigator & Executive Medical Director, Medical City Dallas Hospital, USA

Corresponding Author:

John Nemunaitis, Physician Investigator & Executive Medical Director, Medical City Dallas Hospital, 12222 Merit Drive, Suite 1500, Dallas, Texas 75251, USA, Tel: 214-658-1964; Fax: 214-658-1992; Email: jnemunaitis@marycrowley.org